sellWeak cluster of 510b5-1 plan
Anderson Karen M. sold $284k of CNTA
Chief People Officer at Centessa Pharmaceuticals plc. 16,500 shares at an average of $17.21, traded Dec 13, 2024, filed Dec 17, 2024.
Warning score
14Value
$284k
16,500 shares
Holdings after
71,525
-21% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-24-000182, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 13, 2024 | MOption exercise Ordinary Shares10b5-1 | +5,876 | $3.85 | $23k | 77,401 | Dec 17, 2024 |
| Dec 13, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -5,876 | $17.01 | $100k | 71,525 | Dec 17, 2024 |
| Dec 17, 2024 | MOption exercise Ordinary Shares10b5-1 | +10,624 | $3.85 | $41k | 82,149 | Dec 17, 2024 |
| Dec 17, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -10,624 | $17.32 | $184k | 71,525 | Dec 17, 2024 |
| Dec 13, 2024 | MOption exercise Share Option (right to buy)derivative10b5-1 | -5,876 | $0.00 | $0 | 54,134 | Dec 17, 2024 |
| Dec 17, 2024 | MOption exercise Share Option (right to buy)derivative10b5-1 | -10,624 | $0.00 | $0 | 43,510 | Dec 17, 2024 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 6Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | Weinhoff Gregory M Chief Business Officer | $163k | 10,000 | |
| 49Moderate | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | SAHA SAURABH Chief Executive Officer | $918k | 55,000 | |
| 5Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | CHAO DAVID M Chief Administrative Officer | $120k | 7,000 | |
| 5Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | HUSSAIN IQBAL J General Counsel | $99k | 6,000 | |
| 22Weak | sell 310b5-1 | CNTA Centessa Pharmaceuticals plc | Weinhoff Gregory M Chief Business Officer | $175k | 11,494 | |
| 48Moderate | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | SAHA SAURABH Chief Executive Officer | $876k | 55,000 | |
| 5Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | HUSSAIN IQBAL J General Counsel | $97k | 6,000 | |
| 24Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | Anderson Karen M. Chief People Officer | $589k | 30,955 | |
| 25Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | Anderson Karen M. Chief People Officer | $109k | 6,471 | |
| 22Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | Bush Tia L Chief Technology & Quality Ofc | $185k | 11,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.